Pharmafile Logo
Pharmafocus logo
Advanced Search

orexo

Showing 4 posts of 4 posts found.

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023
Research and Development FDA, Opioid overdose, Pharmacy, opioids, orexo

Orexo has announced that its New Drug Application (NDA) for OX124 has been accepted for review by the US Food …

News
addict-2713526_960_720

EU approves opioid treatment, amid fears of US-like crisis

November 22, 2017
Research and Development, Sales and Marketing Zubsolv, biotech, drugs, opioid, orexo, pharma, pharmaceutical

The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …

News
orexo_logo

AstraZeneca buys rights to Orexo respiratory programme

March 21, 2016
Sales and Marketing AstraZeneca, COPD, asthma, orexo

AstraZeneca has bought the rights to a respiratory programme from Sweden’s Orexo for $5 million. The deal centres on the …

News
Astrazeneca image

AstraZeneca signs respiratory deal

January 29, 2013
Research and Development, Sales and Marketing AstraZeneca, COPD, orexo, respiratory

AstraZeneca has signed a research deal with Swedish pharma company Orexo centred around the development of respiratory disease treatments. For …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025